Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cardiol Therapeutics (CRDL)

Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 98,305
  • Shares Outstanding, K 82,609
  • Annual Sales, $ 0 K
  • Annual Income, $ -20,840 K
  • EBIT $ -28 M
  • EBITDA $ -28 M
  • 60-Month Beta 0.95
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 12.33

Options Overview Details

View History
  • Implied Volatility 411.98% ( +98.22%)
  • Historical Volatility 69.34%
  • IV Percentile 92%
  • IV Rank 30.67%
  • IV High 1,206.81% on 01/15/25
  • IV Low 60.32% on 06/04/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 135
  • Volume Avg (30-Day) 71
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 7,655
  • Open Int (30-Day) 7,507

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.09
  • Growth Rate Est. (year over year) +11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0200 +16.67%
on 03/04/25
1.3200 -9.85%
on 02/21/25
-0.1100 (-8.46%)
since 02/20/25
3-Month
1.0200 +16.67%
on 03/04/25
1.5100 -21.19%
on 02/06/25
-0.0900 (-7.03%)
since 12/20/24
52-Week
1.0200 +16.67%
on 03/04/25
3.1200 -61.86%
on 06/12/24
-0.3600 (-23.23%)
since 03/20/24

Most Recent Stories

More News
Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

Toronto, Ontario--(Newsfile Corp. - March 3, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory...

CRDL.TO : 1.71 (unch)
CRDL : 1.1900 (+0.85%)
Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Data demonstrates improvement in cardiac function and reductions in cardiac hypertrophy, remodeling, inflammation, and cell death - key underlying mechanisms in heart failureToronto, Ontario--(Newsfile...

CRDL.TO : 1.71 (unch)
CRDL : 1.1900 (+0.85%)
Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Toronto, Ontario--(Newsfile Corp. - February 4, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research...

CRDL.TO : 1.71 (unch)
CRDL : 1.1900 (+0.85%)
Zacks Industry Outlook Highlights Corcept, Amneal, Dyne, Nektar and Cardiol

For Immediate ReleaseChicago, IL – February 3, 2025 – Today, Zacks Equity Research discusses Corcept Therapeutics CORT, Amneal Pharmaceuticals AMRX, Dyne Therapeutics DYN, Nektar Therapeutics NKTR...

CORT : 57.12 (-0.82%)
DYN : 11.83 (-3.51%)
CRDL : 1.1900 (+0.85%)
AMRX : 8.87 (-1.55%)
NKTR : 0.8573 (-1.83%)
5 Small Drug Stocks to Add to Your Kitty in the Trump 2.0 Era

The biotech industry has declined since Donald Trump’s election victory. This was mainly because Trump nominated Robert F. Kennedy Jr., a vaccine skeptic, to head the Health and Human Services, the agency...

CORT : 57.12 (-0.82%)
DYN : 11.83 (-3.51%)
CRDL : 1.1900 (+0.85%)
AMRX : 8.87 (-1.55%)
NKTR : 0.8573 (-1.83%)
3 Penny Stocks Ready to Break Out in 2025

Vuzix, GeoVox Labs, and Cardiol Therapeutics emerged as notable penny stocks late in 2024 for their potential to scale operations and launch new products.

VUZI : 2.29 (-0.43%)
CRDL : 1.1900 (+0.85%)
GOVX : 1.3000 (-3.70%)
Buy the Dip: 2 Cannabis ETFs Set to Benefit from Business-Friendly Policies

The recent appointment of Matt Gaetz as Attorney General has sparked controversy - and a surge in cannabis stocks. Two ETFs, AdvisorShares Pure Cannabis ETF (YOLO) and AdvisorShares Pure US Cannabis ETF...

YOLO : 1.9050 (-1.30%)
CURLF : 0.9462 (-4.04%)
SNDL : 1.5600 (-0.64%)
HITI : 2.12 (-0.93%)
VFF : 0.6800 (unch)
CRLBF : 0.7316 (+2.32%)
CRDL : 1.1900 (+0.85%)
TCNNF : 4.0300 (-0.74%)
VRNOF : 0.6500 (-4.41%)
GTBIF : 6.0500 (-1.94%)
MSOS : 2.65 (-1.12%)
Stocks in play: Cardiol Therapeutics Inc.

Reported clinical results from its Phase II open-label MAvERIC-Pilot study investigating the impact ...

CRDL : 1.1900 (+0.85%)
Five Top Heart Health Stocks to Buy Heading into 2025

Heart health statistics are startling. Not only is heart disease the leading cause of death in the United States, it also claims the life of one person every 33 seconds. Plus, the estimated global annual...

ABT : 126.33 (-0.35%)
BSX : 100.34 (-1.15%)
CRDL : 1.1900 (+0.85%)
GILD : 106.58 (+0.67%)
MDT : 90.27 (-1.04%)
Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

Marked and rapid reductions in both pericarditis pain and inflammation  maintained throughout the 26-week studyEpisodes of pericarditis per year substantially reduced MAvERIC-Pilot results support advancing...

CRDL.TO : 1.71 (unch)
CRDL : 1.1900 (+0.85%)

Business Summary

Cardiol Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease. The company's lead product consist CardiolRx(TM). Cardiol Therapeutics Inc. is based in Oakville, ON.

See More

Key Turning Points

3rd Resistance Point 1.2500
2nd Resistance Point 1.2300
1st Resistance Point 1.2100
Last Price 1.1900
1st Support Level 1.1700
2nd Support Level 1.1500
3rd Support Level 1.1300

See More

52-Week High 3.1200
Fibonacci 61.8% 2.3178
Fibonacci 50% 2.0700
Fibonacci 38.2% 1.8222
Last Price 1.1900
52-Week Low 1.0200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar